Ecuador Miguel Pasquel, endocrinologist at Quito’s Metropolitano Hospital and former president of the Ecuadorian Endocrinology Society shares his point of view on the country’s healthcare system. He recognizes the good will of successive governments but regrets their inability to give Ecuadorians access to health across the country, highlighting the differences between…
Lithuania Dr. Rasa Verkauskiene, a key opinion leader in endocrinology in Lithuania, discusses the levels of diabetes in the country and how various stakeholders are working together to combat what is a serious issue, affecting the lives of more than 120,000 Lithuanians. Could you please introduce yourself to our international audience?…
Lithuania Zydrune Visiockene, head of Vilnius University’s Center of Endocrinology and a key opinion leader on the topic of diabetes in the Baltics, casts his expert eye over the disease’s prevalence in Lithuania as well as the private and public sector initiatives currently underway to counter this important public health threat.…
Poland Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant market in the region and the on-going commitment to make innovative treatment options available for patients. Furthermore, he discusses Novo Nordisk’s strong commitment to social responsibility in each country throughout the region and the need…
Serbia Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the West Balkan region, and the company’s dedication to providing unique and efficient solutions for diabetes and concomitant complications. Could you…
Lithuania Marijus Valatka, general manager Lithuania, Latvia and Estonia at Novo Nordisk, explains the current challenges and areas for improvement in diabetes treatment in Lithuania and stresses the company’s commitment to not only bring medicines to the market but also enhance the quality of treatment fort diabetes and other serious chronic…
Brazil Allan Finkel, recently voted Novo Nordisk’s best GM globally, speaks about the partnerships and projects that the Brazilian affiliate organizes with doctors and patient associations to increase diabetes awareness in the country as well as their newly launched obesity treatment Saxenda®, which has seen tremendous success in Brazil. You took…
Bulgaria Ivan Kolev, country manager at Wörwag Pharma Bulgaria, explains how has the affiliate performed over the last years as well as shares an overview about the development of diabetes and its complications, and pain management in the country. You have had two different stages at Wörwag Pharma; working in Actavis…
Tunisia Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of diabetes and lack of awareness thereof in Tunisia, the company’s ambition to launch a series of new products to the market, and Novo Nordisk’s continuing dedication to the…
Canada Brian Hilberdink, President of Novo Nordisk Canada, highlights the key role that Canada plays as a pilot market for exporting best practices globally, the focus that Novo Nordisk is placing on the undertreated condition of obesity in Canada, and the challenges and opportunities of running an innovative pharma business in…
Tunisia Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes is the second largest cause of death in Tunisia”. Moez Lindhallah Mokadem, director of Pharmacie Centrale de Tunisie (PCT), adds…
See our Cookie Privacy Policy Here